Most cancers
Researchers from Molecular Companions AG reported on the preclinical analysis of MP-0533, a multispecific T-cell partaking DARPin (designed ankyrin repeat protein) concentrating on CD70, CD123, CD33 and CD3 tumor-associated antigens (TAA) concurrently.
